Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001209191-20-052463

CMO and Head of R&D acquired 3,844 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
PRASAD SUYASH CMO and Head of R&D 2020-09-28 Conversion +3,844 672,589 D
Derivatives
PRASAD SUYASH CMO and Head of R&D 2020-09-28 Conversion · Series B Preferred Stock −3,529 0 D
Loading xslF345X03/doc4.xml…